|
|
|
|
FOCUS ON PROCESS ENGINEERING |
|
|
|
By Bioprocess Online Live | In Part 2 of this conversation on “Better Biopharma,” panelists from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration” continue their discussion about how upstream and downstream development teams can work together to accelerate timelines and reduce risk and bottlenecks in process development. | |
|
|
|
|
| Direct Cell Lysis Enables Rapid Vector Copy Number (VCN) Quantification | Application Note | By Anne Schieren, Philipp Rink, Anida Karamitsos, et al., QIAGEN | Explore a faster approach to vector copy number measurement that replaces DNA extraction with direct cell lysis and digital PCR, delivering accurate, reproducible results across fresh and frozen samples. |
|
|
|
| Digital Innovation And Sustainability Are Redefining Biomanufacturing | White Paper | By Dr. Harald Bradl and Dr. Fabian Vogt, Boehringer Ingelheim Biopharmaceuticals GmbH | Next Generation Manufacturing (NGM) integrates advanced process design, digital innovation, and strategic facility planning to facilitate agile, efficient, and sustainable biopharmaceutical production. |
|
|
|
|
| Tips For Viral Vector Production | Article | Cytiva | Read about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements. |
|
|
|
|
| Levers To Optimize The IVT Reaction For Increased mRNA Yield | Application Note | By Alexander Latta, Neera Sammeta, Stefan Kutter, et al., Roche CustomBiotech | Mastering IVT yield requires balancing magnesium and nucleotide ratios. Learn how specific buffers and pyrophosphatase optimize mRNA synthesis for scalable, high-quality therapeutic production. |
|
|
PROCESS ENGINEERING SOLUTIONS |
|
|
|
|
|
|
|
| Webinar: Using Residual DNA Quantification Data to De-risk mAb Development | IND-stage analytical methods must support validation, tech transfer, and evolving regulatory expectations. In this webinar, learn how residual host cell DNA quantitation can guide downstream mAb process decisions, assess impurity clearance, and identify risks early. Explore assay performance in protein-rich matrices and strategies for building scalable, validation-ready workflows that remain robust through manufacturing and commercial production environments globally. Click here to learn more. |
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|